Apollon Wealth Management’s iShares US Medical Devices ETF IHI Stock Holding History

Apollon Wealth Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$853K	Sell	17,259 -3,676	-18%	-$187K	0.01%	793
2026 Q1	$1.12M	Sell	20,935 -2,747	-12%	-$161K	0.02%	565
2025 Q4	$1.47M	Sell	23,682 -2,429	-9%	-$150K	0.03%	451
2025 Q3	$1.57M	Sell	26,111 -972	-4%	-$59.5K	0.03%	440
2025 Q2	$1.7M	Buy	27,083 +118	+0.4%	+$7.09K	0.03%	402
2025 Q1	$1.62M	Sell	26,965 -1,494	-5%	-$92.8K	0.04%	375
2024 Q4	$1.66M	Buy	28,459 +21,250	+295%	+$1.26M	0.04%	377
2024 Q3	$427K	Buy	7,209 +38	+0.5%	+$2.17K	0.01%	785
2024 Q2	$402K	Sell	7,171 -2,134	-23%	-$119K	0.01%	763
2024 Q1	$545K	Hold	9,305	–	–	0.02%	665
2023 Q4	$502K	Sell	9,305 -491	-5%	-$24K	0.02%	649
2023 Q3	$475K	Sell	9,796 -99,368	-91%	-$5.28M	0.02%	561
2023 Q2	$6.16M	Buy	109,164 +100,265	+1,127%	+$5.52M	0.3%	69
2023 Q1	$480K	Sell	8,899 -2,090	-19%	-$111K	0.03%	543
2022 Q4	$578K	Buy	10,989 +2,934	+36%	+$149K	0.04%	462
2022 Q3	$380K	Sell	8,055 -53	-0.7%	-$2.75K	0.03%	528
2022 Q2	$409K	Sell	8,108 -20	-0.2%	-$1.09K	0.03%	480
2022 Q1	$495K	Sell	8,128 -485	-6%	-$28.9K	0.04%	468
2021 Q4	$567K	Buy	+8,613	New	+$551K	0.04%	431
2021 Q1	–	Sell	-31,752	Closed	-$1.73M	–	353
2020 Q4	$1.73M	Buy	+31,752	New	+$1.66M	0.47%	50
2020 Q3	–	Sell	-1,290	Closed	-$57K	–	395
2020 Q2	$57K	Buy	+1,290	New	+$55.1K	0.03%	227

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Apollon Wealth Management's IHI Position: Q2 2026 in Review

Apollon Wealth Management reduced its iShares US Medical Devices ETF (IHI) stake by 18% in Q2 2026, selling an estimated $187K and leaving 17,259 shares worth $853K. The position accounts for 0.01% of the portfolio, ranked #793.

Apollon Wealth Management first reported a position in IHI in Q2 2020 and has held it in 21 quarters since. The position peaked at $6.16M in Q2 2023. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Apollon Wealth Management held 17,259 shares of iShares US Medical Devices ETF worth $853K as of Q2 2026.
Apollon Wealth Management sold 3,676 iShares US Medical Devices ETF shares in Q2 2026, an estimated $187K.
iShares US Medical Devices ETF made up 0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #793 holding.
Apollon Wealth Management first reported a position in iShares US Medical Devices ETF in Q2 2020 and has held it in 21 quarters since.
Apollon Wealth Management's iShares US Medical Devices ETF position peaked at $6.16M in Q2 2023.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.